-
1
-
-
0026633925
-
Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease
-
10.1146/annurev.nu.12.070192.001431 1503807
-
Kang S Wong P Malinow M Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease Annu Rev Nutr 1992, 12:279-98. 10.1146/ annurev.nu.12.070192.001431 1503807
-
(1992)
Annu Rev Nutr
, vol.12
, pp. 279-298
-
-
Kang, S.1
Wong, P.2
Malinow, M.3
-
2
-
-
0032499024
-
Homocysteine and atherothrombosis
-
50 10.1056/NEJM199804093381507 9535670
-
Welch G Loscalzo J Homocysteine and atherothrombosis N Engl J Med 1998, 338(15):1042-50. 10.1056/NEJM199804093381507 9535670
-
(1998)
N Engl J Med
, vol.338
, Issue.15
, pp. 1042-1050
-
-
Welch, G.1
Loscalzo, J.2
-
3
-
-
0029066299
-
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
-
10.1001/jama.274.13.1049 7563456
-
Boushey CJ Beresford SA Omenn Motulsky AG A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes JAMA 1995, 274(13):1049-57. 10.1001/jama.274.13.1049 7563456
-
(1995)
JAMA
, vol.274
, Issue.13
, pp. 1049-1057
-
-
Boushey, C.J.1
Beresford, S.A.2
Omenn3
Motulsky, A.G.4
-
4
-
-
0037164375
-
Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis
-
135491 12446535 10.1136/bmj.325.7374.1202
-
Wald D Law M Morris J Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis BMJ 2002, 325(7374):1202 135491. 12446535 10.1136/bmj.325.7374.1202
-
(2002)
BMJ
, vol.325
, pp. 1202
-
-
Wald, D.1
Law, M.2
Morris, J.3
-
5
-
-
0037164104
-
Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis
-
Homocysteine Studies Collaboration 10.1001/jama.288.16.2015 12387654
-
Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis JAMA 2002, 288:2015-2022. 10.1001/jama.288.16.2015 12387654
-
(2002)
JAMA
, vol.288
, pp. 2015-2022
-
-
-
6
-
-
33845503323
-
Effect of folic acid supplementation on risk of cardiovascular diseases: A meta-analysis of rendomized controlled trials
-
Erratum in: JAMA. 2007 Mar 7;297(9):952
-
Bazzano LA Reynolds K Holder KN He J Effect of folic acid supplementation on risk of cardiovascular diseases: A meta-analysis of rendomized controlled trials JAMA 2006, 296(22):2720-6. Erratum in: JAMA. 2007 Mar 7;297(9):952
-
(2006)
JAMA
, vol.296
, Issue.22
, pp. 2720-2726
-
-
Bazzano, L.A.1
Reynolds, K.2
Holder, K.N.3
He, J.4
-
7
-
-
33645753544
-
Homocysteine lowering with folic acid and B vitamins in vascular disease
-
The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators 10.1056/ NEJMoa060900 16531613
-
The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators Homocysteine lowering with folic acid and B vitamins in vascular disease N Engl J Med 2006, 354:1567-1577. 10.1056/NEJMoa060900 16531613
-
(2006)
N Engl J Med
, vol.354
, pp. 1567-1577
-
-
-
8
-
-
1342309318
-
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial
-
10.1001/jama.291.5.565 10.1001/jama.291.5.565 14762035
-
Toole J Malinow M Chambless L et al Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial JAMA 2004, 291:565-575. 10.1001/ jama.291.5.565 14762035
-
(2004)
JAMA
, vol.291
, pp. 565-575
-
-
Toole, J.1
Malinow, M.2
Chambless, L.3
-
9
-
-
33645796222
-
Homocysteine lowering and cardiovascular events after acute myocardial infarction
-
10.1056/NEJMoa055227 16531614
-
Bønaa K Njølstad I Ueland P et al Homocysteine lowering and cardiovascular events after acute myocardial infarction N Engl J Med 2006, 354:1578-1588. 10.1056/NEJMoa055227 16531614
-
(2006)
N Engl J Med
, vol.354
, pp. 1578-1588
-
-
Bønaa, K.1
Njølstad, I.2
Ueland, P.3
-
10
-
-
33645777279
-
Homocysteine trials - Clear Outcomes for Complex reasons
-
10.1056/NEJMe068060 16531615
-
Joseph Loscalzo Homocysteine trials - Clear Outcomes for Complex reasons N Engl J Med 2006, 354(15):1629-32. 10.1056/NEJMe068060 16531615
-
(2006)
N Engl J Med
, vol.354
, Issue.15
, pp. 1629-1632
-
-
Loscalzo, J.1
-
11
-
-
0014545138
-
Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
-
2013581 5792556
-
McCully K Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis Am J Pathol 1969, 56:111-28. 2013581 5792556
-
(1969)
Am J Pathol
, vol.56
, pp. 111-128
-
-
McCully, K.1
-
12
-
-
0036963414
-
Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia
-
10.1191/1358863x02vm428ra 12553746
-
Keller C Hoffman U Loscalzo J Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia Vascular Medicine 2002, 7(3):227-239. 10.1191/1358863x02vm428ra 12553746
-
(2002)
Vascular Medicine
, vol.7
, Issue.3
, pp. 227-239
-
-
Keller, C.1
Hoffman, U.2
Loscalzo, J.3
-
13
-
-
28344446460
-
Mechanisms of homocysteine-induced atherothrombosis
-
10.1111/j.1538-7836.2005.01364.x 16102030
-
Lentz S Mechanisms of homocysteine-induced atherothrombosis J Thromb Haemost 2005, 3(8):1646-54. 10.1111/j.1538-7836.2005.01364.x 16102030
-
(2005)
J Thromb Haemost
, vol.3
, Issue.8
, pp. 1646-1654
-
-
Lentz, S.1
-
14
-
-
51649112963
-
Murine models of hyperhomocysteinemia and their vascular phenotypes
-
2574668 18556571 10.1161/ATVBAHA.108.166421
-
Dayal S Lentz S Murine models of hyperhomocysteinemia and their vascular phenotypes Arterioscler Thromb Vasc Biol 2008, 28(9):1596-605. 2574668 18556571 10.1161/ATVBAHA.108.166421
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, Issue.9
, pp. 1596-1605
-
-
Dayal, S.1
Lentz, S.2
-
15
-
-
0035107609
-
Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model
-
208940 11254667 10.1172/JCI10588
-
Hofmann M Lalla E Gleason M Kohl B Wolf B Kiesel W Stern D Schmidt A Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model J Clin Invest 2001, 107(6):675-83. 208940 11254667 10.1172/JCI10588
-
(2001)
J Clin Invest
, vol.107
, Issue.6
, pp. 675-683
-
-
Hofmann, M.1
Lalla, E.2
Gleason, M.3
Kohl, B.4
Wolf, B.5
Kiesel, W.6
Stern, D.7
Schmidt, A.8
-
16
-
-
2942752021
-
Folate therapy and in-stent restenosis after coronary stenting
-
10.1056/NEJMoa032845 15215483
-
Lange H Suryapranata H De Luca G Börner C Dille J Kallmayer K Pasalary MN Scherer E Dambrink JH Folate therapy and in-stent restenosis after coronary stenting N Engl J Med 2004, 350(26):2673-81. 10.1056/ NEJMoa032845 15215483
-
(2004)
N Engl J Med
, vol.350
, Issue.26
, pp. 2673-2681
-
-
Lange, H.1
Suryapranata, H.2
De Luca, G.3
Börner, C.4
Dille, J.5
Kallmayer, K.6
Pasalary, M.N.7
Scherer, E.8
Dambrink, J.H.9
-
17
-
-
27944476897
-
Venous thromboembolism and hyperhomocysteinemia as first manifestation of pernicious anemia
-
10.1157/13079763 16238959
-
Fernandez C Yebra M Ribera C Toledo T Martin M Gomez P Venous thromboembolism and hyperhomocysteinemia as first manifestation of pernicious anemia Rev Clin Esp 2005, 205(10):489-92. 10.1157/13079763 16238959
-
(2005)
Rev Clin Esp
, vol.205
, Issue.10
, pp. 489-492
-
-
Fernandez, C.1
Yebra, M.2
Ribera, C.3
Toledo, T.4
Martin, M.5
Gomez, P.6
-
18
-
-
33747086863
-
Hyperhomocysteinaemia, thrombosis and pernicious anaemia
-
16894471
-
Limal N Scheuermaier K Tazi Z Sene D Piette J Cacoub P Hyperhomocysteinaemia, thrombosis and pernicious anaemia Thromb Haemost 2006, 96(2):233-5. 16894471
-
(2006)
Thromb Haemost
, vol.96
, Issue.2
, pp. 233-235
-
-
Limal, N.1
Scheuermaier, K.2
Tazi, Z.3
Sene, D.4
Piette, J.5
Cacoub, P.6
-
19
-
-
45749106731
-
Hyperhomocysteinemia due to pernicious anemia leading to pulmonary thromboembolism in a heterozygous mutation carrier
-
10.1177/1076029607305101 18586684
-
Küpeli E Cengiz C Cila A Karnak D Hyperhomocysteinemia due to pernicious anemia leading to pulmonary thromboembolism in a heterozygous mutation carrier Clin Appl Thromb Hemost 2008, 14(3):365-8. 10.1177/ 1076029607305101 18586684
-
(2008)
Clin Appl Thromb Hemost
, vol.14
, Issue.3
, pp. 365-368
-
-
Küpeli, E.1
Cengiz, C.2
Cila, A.3
Karnak, D.4
-
20
-
-
0033812945
-
Genetic modulation of homocysteinemia
-
10.1055/s-2000-8470 11011843
-
Rozen R Genetic modulation of homocysteinemia Semin Thromb Hemost 2000, 26:255-261. 10.1055/s-2000-8470 11011843
-
(2000)
Semin Thromb Hemost
, vol.26
, pp. 255-261
-
-
Rozen, R.1
-
21
-
-
38049152741
-
In vitamin b12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentration
-
2148411 18056804 10.1073/pnas.0709487104
-
Selhub J Morris MS Jaques PF In vitamin b12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentration PNAS 2007, 104(50):19995-20000. 2148411 18056804 10.1073/pnas.0709487104
-
(2007)
PNAS
, vol.104
, Issue.50
, pp. 19995-20000
-
-
Selhub, J.1
Morris, M.S.2
Jaques, P.F.3
|